Skip to main content
Year archive

TELCON RF PHARMACEUTICAL. Inc. — 2020 filings

All 53 regulatory filings released by TELCON RF PHARMACEUTICAL. Inc. (200230) in 2020, sourced directly from the official regulator.

53 Filings
2020 Period
2020 filings (53)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-15 Korean
전환청구권행사
Share Issue/Capital Change
2020-11-23 Korean
합병등종료보고서(자산양수도)
M&A Activity
2020-11-20 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-11-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change
2020-11-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-11-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change
2020-11-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-11-06 Korean
합병등종료보고서(자산양수도)
M&A Activity
2020-11-04 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-11-04 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-11-04 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-11-04 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-11-03 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-11-03 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-11-03 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity
2020-11-03 Korean
주요사항보고서(주권관련사채권양수결정)
Capital/Financing Update
2020-11-03 Korean
투자판단관련주요경영사항(렌질루맙(Lezilumab, COVID-19 치료제)의 한국 및 필리핀 라이선스 도입 계약 체결)
M&A Activity
2020-11-03 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-10-16 Korean
증권발행결과(자율공시)
Capital/Financing Update
2020-10-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-09-28 Korean
[기재정정]투자판단관련주요경영사항(SCD API(겸상적혈구질환 치료제 원료의약품)의 독점공급권 계약 체결)
Legal Proceedings Report
2020-09-28 Korean
[기재정정]주요사항보고서(중요한자산양수도결정(기타))
M&A Activity
2020-09-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-09-04 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-08-07 Korean
본점소재지변경
Regulatory Filings
2020-07-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-06-11 Korean
증권발행결과(자율공시)(제14회차 CB)
Capital/Financing Update
2020-06-08 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-06-04 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-05-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-05-28 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-05-08 Korean
주주총회소집공고
AGM Information
2020-04-24 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-04-24 Korean
전환가액의조정(제13회차)
Capital/Financing Update
2020-03-31 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-27 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-27 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Regulatory Filings
2020-03-19 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-19 Korean
전환가액의조정(제7회차)
Capital/Financing Update
2020-03-16 Korean
주주총회소집공고
AGM Information
2020-03-02 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-02 Korean
주주총회집중일개최사유신고
AGM Information
2020-03-02 Korean
전환가액의조정(제13회차)
Capital/Financing Update
2020-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-28 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-02-28 Korean